Over 150 delegates gathered in Dubai for the Microbiome and Genomics Revolution Symposium, focusing on advancements in microbiome science, genomics, and artificial intelligence (AI) for personalized medicine. The genomics market is anticipated to expand from USD 39.5 billion in 2024 to USD 157.5 billion by 2033, while the microbiome market could surpass USD 4.2 billion by 2030. Healthcare spending in the UAE is projected to exceed USD 200 billion by 2025. Discussions emphasized the need for equitable access to innovations and highlighted the role of microbiome diversity and microbial immunotherapies in enhancing health outcomes, particularly in women’s health.